
簡要描述:Zomepirac sodium salt 64092-48-4Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.
產(chǎn)品分類
Product Category詳細(xì)介紹
| 品牌 | absin | CAS | 64092-48-4 |
|---|---|---|---|
| 分子式 | C15H13ClNNaO3 | 純度 | >98% |
| 分子量 | 313.71 | 貨號 | abs47026953 |
| 規(guī)格 | 100mg | 供貨周期 | 現(xiàn)貨 |
| 主要用途 | and UK markets in March 1983. | 應(yīng)用領(lǐng)域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
Zomepirac sodium salt 64092-48-4
| 產(chǎn)品描述 | |
| 描述 | Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions. The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983. |
| 純度 | >98% |
| 儲(chǔ)存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | 佐美酸鈉;McN-2783-21-98 |
| 外觀 | Pale Yellow Solid |
| 可溶性/溶解性 | H2O: ≥ 100 mg/mL |
| 生物活性 | |
| 靶點(diǎn) | PGE synthase |
| 參考文獻(xiàn) | |
| 參考文獻(xiàn) |
|
| 研究領(lǐng)域 | |
| 研究領(lǐng)域 | Immunology Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產(chǎn)品咨詢
